PBM PSYENCE BIOMEDICAL LTD.

Nasdaq


$ 2.97 $ -0.16 (-5.11 %)    

Monday, 03-Nov-2025 15:24:43 EST
QQQ $ 631.85 $ -3.37 (-0.53 %)
DIA $ 473.55 $ -2.59 (-0.54 %)
SPY $ 683.21 $ -2.42 (-0.35 %)
TLT $ 89.61 $ -0.04 (-0.05 %)
GLD $ 368.91 $ 0.11 (0.03 %)
$ 3.16
$ 3.08
$ 2.88 x 200
$ 3.00 x 50
$ 2.90 - $ 3.08
$ 2.36 - $ 63.36
35,232
na
nm
$ 1.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing...

Core News & Articles

- SEC Filing

Core News & Articles

https://www.sec.gov/Archives/edgar/data/1985062/000121390025096665/ea0254854-f1a1_psyence.htm

 psyence-biomed-pbm-shares-soar-on-ibogaine-production-breakthrough

Shares of Psyence Biomedical are surging Thursday morning. The stock is gaining following an announcement from the company and ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION